Lexicon, Poniard lead decliners

Shares of Lexicon Pharmaceuticals and Poniard Pharmaceuticals weaken in the early action, standing out in a largely unmoved sector.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.